Moor CC[au] - Search Results

Year	Number of Results
2010	1
2017	3
2018	3
2019	5
2020	11
2021	6

1

Inflammation and immunity in IPF pathogenesis and treatment.

Heukels P, Moor CC, von der Thüsen JH, Wijsenbeek MS, Kool M. Heukels P, et al. Among authors: moor cc. Respir Med. 2019 Feb;147:79-91. doi: 10.1016/j.rmed.2018.12.015. Epub 2019 Jan 9. Respir Med. 2019. PMID: 30704705 Free article. Review.

2

Acute exacerbation of idiopathic pulmonary fibrosis: international survey and call for harmonisation.

Kreuter M, Polke M, Walsh SLF, Krisam J, Collard HR, Chaudhuri N, Avdeev S, Behr J, Calligaro G, Corte T, Flaherty K, Funke-Chambour M, Kolb M, Kondoh Y, Maher TM, Molina Molina M, Morais A, Moor CC, Morisset J, Pereira C, Quadrelli S, Selman M, Tzouvelekis A, Valenzuela C, Vancheri C, Vicens-Zygmunt V, Wälscher J, Wuyts W, Wijsenbeek M, Cottin V, Bendstrup E. Kreuter M, et al. Among authors: moor cc. Eur Respir J. 2020 Apr 3;55(4):1901760. doi: 10.1183/13993003.01760-2019. Print 2020 Apr. Eur Respir J. 2020. PMID: 32060068 Free article.

3

Desquamative interstitial pneumonia: a systematic review of its features and outcomes.

Hellemons ME, Moor CC, von der Thüsen J, Rossius M, Odink A, Thorgersen LH, Verschakelen J, Wuyts W, Wijsenbeek MS, Bendstrup E. Hellemons ME, et al. Among authors: moor cc. Eur Respir Rev. 2020 Jun 23;29(156):190181. doi: 10.1183/16000617.0181-2019. Print 2020 Jun 30. Eur Respir Rev. 2020. PMID: 32581140 Free article.

4

Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial.

Moor CC, Mostard RLM, Grutters JC, Bresser P, Aerts JGJV, Chavannes NH, Wijsenbeek MS. Moor CC, et al. Am J Respir Crit Care Med. 2020 Aug 1;202(3):393-401. doi: 10.1164/rccm.202002-0328OC. Am J Respir Crit Care Med. 2020. PMID: 32325005 Clinical Trial.

5

Comprehensive Care for Patients with Sarcoidosis.

Moor CC, Kahlmann V, Culver DA, Wijsenbeek MS. Moor CC, et al. J Clin Med. 2020 Feb 1;9(2):390. doi: 10.3390/jcm9020390. J Clin Med. 2020. PMID: 32024123 Free PMC article. Review.

6

Managing Fatigue in Patients With Interstitial Lung Disease.

Kahlmann V, Moor CC, Wijsenbeek MS. Kahlmann V, et al. Among authors: moor cc. Chest. 2020 Nov;158(5):2026-2033. doi: 10.1016/j.chest.2020.04.047. Epub 2020 May 7. Chest. 2020. PMID: 32387518 Free PMC article. Review.

7

Research highlights from the 2018 ERS International Congress: interstitial lung diseases.

Alfaro TM, Moor CC, Alfieri V, Jeny F, Kreuter M, Wijsenbeek MS, Renzoni EA, Bargagli E, Nunes H, Spagnolo P, Bonella F, Molina-Molina M, Antoniou K, Poletti V. Alfaro TM, et al. Among authors: moor cc. ERJ Open Res. 2019 Feb 18;5(1):00215-2018. doi: 10.1183/23120541.00215-2018. eCollection 2019 Feb. ERJ Open Res. 2019. PMID: 30792985 Free PMC article. Review.

8

Home monitoring for patients with ILD and the COVID-19 pandemic.

Nakshbandi G, Moor CC, Wijsenbeek MS. Nakshbandi G, et al. Among authors: moor cc. Lancet Respir Med. 2020 Dec;8(12):1172-1174. doi: 10.1016/S2213-2600(20)30452-5. Epub 2020 Oct 16. Lancet Respir Med. 2020. PMID: 33075296 Free PMC article. No abstract available.

9

Feasibility of a Comprehensive Home Monitoring Program for Sarcoidosis.

Moor CC, Gür-Demirel Y, Wijsenbeek MS. Moor CC, et al. J Pers Med. 2019 May 5;9(2):23. doi: 10.3390/jpm9020023. J Pers Med. 2019. PMID: 31060343 Free PMC article.

10

Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease.

Moor CC, Oppenheimer JC, Nakshbandi G, Aerts JGJV, Brinkman P, Maitland-van der Zee AH, Wijsenbeek MS. Moor CC, et al. Eur Respir J. 2021 Jan 5;57(1):2002042. doi: 10.1183/13993003.02042-2020. Print 2021 Jan. Eur Respir J. 2021. PMID: 32732331

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results